6:14 PM
 | 
Sep 19, 2007
 |  BC Extra  |  Financial News

Neurobiological Technologies amends follow-on

NTII amended its proposed follow-on and now hopes to sell 16.5 million shares in the offering. If sold at Tuesday's close of $3.95, the...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >